Temomedak (temozolomide) capsules 180 mg. #5

$945.20

Manufactured in: Germany

Temozolomide capsules are used to treat certain types of brain cancer by disrupting cancer cell DNA replication, leading to cell death.

SKU: MED8082 Category:

Description

Temomedak (temozolomide) Capsules 180 mg.

Temomedak is a medication that comes in the form of capsules containing 180 mg. of the active ingredient temozolomide. It is commonly prescribed to treat certain types of cancer, such as glioblastoma multiforme and anaplastic astrocytoma. Temozolomide belongs to a class of drugs known as alkylating agents, which work by interfering with the DNA replication process in cancer cells, ultimately leading to their destruction.

Indications

Temomedak capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme as well as for the treatment of refractory anaplastic astrocytoma. It is typically used in combination with radiation therapy for glioblastoma multiforme and as monotherapy for anaplastic astrocytoma.

How It Works

As an alkylating agent, temozolomide works by attaching alkyl groups to the DNA molecule, which prevents the cancer cells from replicating and dividing. This leads to cell death and reduces the growth of the tumor. Temozolomide is specifically designed to cross the blood-brain barrier, making it effective in treating brain tumors such as glioblastoma multiforme.

Dosage and Administration

Temomedak capsules are typically taken orally, with or without food. The dosage and treatment schedule will depend on the specific type of cancer being treated and the patient’s overall health condition. It is important to follow your healthcare provider’s instructions carefully and not to change the dosage without consulting them first.

For glioblastoma multiforme, temozolomide is usually taken once daily for 42 days in combination with radiation therapy, followed by a rest period, and then continued as monotherapy. For anaplastic astrocytoma, it is taken once daily for 5 consecutive days every 28 days.

Side Effects

Like all medications, temozolomide may cause side effects in some patients. Common side effects include nausea, vomiting, fatigue, loss of appetite, and hair loss. More serious side effects, although rare, may include decreased blood cell counts, liver problems, and allergic reactions.

If you experience any side effects while taking Temomedak, it is important to inform your healthcare provider immediately. They may adjust your dosage or provide supportive care to help manage the side effects.

Precautions

Before taking Temomedak, inform your healthcare provider about any allergies you may have, as well as any other medications you are currently taking. It is important to avoid becoming pregnant or fathering a child while taking temozolomide, as it may harm the unborn baby.

It is also important to have regular blood tests to monitor your blood cell counts while taking temozolomide, as it may cause a decrease in white blood cells, red blood cells, and platelets. Your healthcare provider will advise you on the necessary precautions to take to minimize the risk of infection or bleeding.

Storage

Temomedak capsules should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets, and do not use it past the expiration date printed on the packaging.

Conclusion

Temomedak (temozolomide) capsules 180 mg. are an important medication used in the treatment of certain types of cancer, particularly brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. By interfering with the DNA replication process in cancer cells, temozolomide helps to slow down tumor growth and improve patient outcomes.

It is essential to follow your healthcare provider’s instructions carefully when taking Temomedak and to report any side effects or concerns promptly. With proper monitoring and care, temozolomide can be an effective treatment option for patients battling cancer.